HOKUYAKU TAKEYAMA Holdings,Inc. (3055) Stock Price

Hokuyaku Takeyama Holdings is a holding company with pharmaceutical and medical device wholesale as its core business, alongside multiple other operations including the operation of dispensing pharmacies, rental and operation of care equipment facilities, and information services for the medical sector. The company's main focus is the supply of prescription and over-the-counter pharmaceuticals and the sale of medical devices, while also providing dispensing services, care services, logistics for hospitals, and business launch support.

Key customers include hospitals, clinics, pharmacies, and care facilities, as well as the agricultural and livestock industries requiring pharmaceutical products. Revenue is primarily composed of wholesale sales, followed by pharmacy dispensing sales and dispensing fees, care equipment rental and facility operation income, and IT and consulting service revenue, with income diversified across multiple business segments.

Operations are divided into six segments: "Pharmaceutical Wholesale," "Medical Device Wholesale," "Pharmacy Business," "Care Business," "IT (Information Services) Business," and "Other (Holding Company Operations)," with each group company handling its respective field. For example, pharmaceutical wholesale is led by Hokuyaku and Lead Specialties; medical device wholesale by Takeyama and Nova Medical; pharmacies by Soeru and Crane Pharmacy; care services by Mulberry and Morse; and IT by Adwick. The company has recently undergone group restructuring, including the acquisition of AX (July 2024) and the transfer of insurance agency operations (January 2025).

Under its Sixth Medium-Term Management Plan, Hokuyaku Takeyama Holdings is positioning transformation into a "regionally rooted comprehensive healthcare group based in Hokkaido" as the core of its growth strategy. Building on its pharmaceutical and medical device wholesale business, the company is strengthening seamless service delivery tailored to regional healthcare needs by integrating dispensing pharmacies, care services, and medical information services. As a concrete initiative, the company has scaled up "Area Summits" attended by the president and regional leaders starting in the fiscal year ending March 2024, accelerating regional strategy planning and execution. The company aims to enhance its regional presence and establish a sustainable revenue foundation.

Priority investment areas are human capital and business digitalization, which serve as sources of competitive differentiation. Under the banner of maximizing employee capabilities, the company is advancing talent utilization through education and training, workplace environment improvements, and company-wide discussion forums (the "Open Council Meetings"). Leveraging frontline customer touchpoints across wholesale, pharmacy, and care operations, the company can provide integrated one-stop services with stronger regional proximity than competitors, establishing competitive advantage. Additionally, the company continues investing in value-added services directly connected to operations, such as logistics and hospital opening support.

The company actively pursues new market development and business restructuring. Anticipating expanded demand for home-based medical care and long-term care services accompanying population aging, it plans to expand rental of care equipment, facility operations, and home healthcare services. As concrete examples of group restructuring, the company executed the acquisition of AX Corporation (July 2024) and the transfer of its insurance agency business (January 2025), optimizing its business portfolio. To address demand with significant regional variation, the company is strengthening strategy execution based on regional analysis and pursuing service expansion integrated with hospitals, clinics, and pharmacies.

In technological innovation, the company positions Digital Transformation (DX) as a critical pillar, advancing it across four priority areas: business collaboration support for integrated regional care, operational process reform for efficiency, management data visualization and database development, and alignment with national healthcare DX initiatives and telemedicine. Combined with the Sustainability Committee established in February 2024, the company seeks to create new value through digital operational efficiency and service quality improvement, aiming to realize sustainable regional healthcare.